There are unique features of renal oxygenation that render the kidney susceptible to oxygen demand-supply mismatch and hypoxia. Renal oxygen consumption by oxidative metabolism is closely coupled to and driven by tubular transport, which is linked to the filtered solute load and glomerular filtration rate (GFR). In turn, filtered solute load and GFR are dependent on the renal blood flow. Hence, changes in renal blood flow increase oxygen delivery but also increase oxygen demand (consumption) simultaneously by increasing the tubular workload of solute transport. The renal blood flow to different regions of kidney is also inhomogeneous, increasing the oxygen demand-supply mismatch in particular areas such as the outer medulla which become more susceptible to injury. Thus, tubular transport and oxidative metabolism by miochondria are closely coupled in the kidney and are the principal determinants of intrarenal oxygenation. Here we review the published literature characterizing renal oxygenation and mitochondrial function in ischemic and sepsis-associated acute kidney injury (AKI). However, the coupling of transport and metabolism in AKI has not been examined. This is a potentially fruitful area of research that should become increasingly active given the emerging data linking renal oxygenation and hypoxia to acute and chronic dysfunction in the kidney.

Keywords:
Oxygenation, Mitochondrial function, Metabolism, Transport
1.
Evans RG, et al: Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Am J Physiol Renal Physiol 2008;295:F1259-F1270.
2.
Cohen JJ: Renal metabolism: relation to renal function; in Brenner BM (ed): The Kidney. Philadelphia, Saunders, 1981.
3.
Deetjen P, Kramer K: The relation of O2 consumption by the kidney to Na re-resorption (in German). Pflügers Arch Gesamte Physiol Menschen Tiere 1961;273:636-650.
4.
Mandel LJ: Primary active sodium transport, oxygen consumption, and ATP: coupling and regulation. Kidney Int 1986;29:3-9.
5.
Epstein FH, Agmon Y, Brezis M: Physiology of renal hypoxia. Ann NY Acad Sci 1994;718:72-81, discussion 81-82.
6.
Addabbo F, Montagnani M, Goligorsky MS: Mitochondria and reactive oxygen species. Hypertension 2009;53:885-892.
7.
Westermann B: Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta 2012;1817:1833-1838.
8.
Legrand M, Almac E, Mik EG, et al: L-NIL prevents renal microvascular hypoxia and increase of renal oxygen consumption after ischemia-reperfusion in rats. Am J Physiol Renal Physiol 2009;296:F1109-F1117.
9.
Oostendorp M, de Vries EE, Slenter JM, Peutz-Kootstra CJ, Snoeijs MG, Post MJ, van Heurn LW, Backes WH: MRI of renal oxygenation and function after normothermic ischemia-reperfusion injury. NMR Biomed 2011;24:194-200.
10.
Pohlmann A, Hentschel J, Fechner M, Hoff U, Bubalo G, Arakelyan K, Cantow K, Seeliger E, Flemming B, Waiczies H, Waiczies S, Schunck WH, Dragun D, Niendorf T: High temporal resolution parametric MRI monitoring of the initial ischemia/reperfusion phase in experimental acute kidney injury. PLoS One 2013;8:e57411.
11.
Ricksten SE, Bragadottir G, Redfors B: Renal oxygenation in clinical acute kidney injury. Crit Care 2013;17:221.
12.
Redfors B, et al: Acute renal failure is NOT an ‘acute renal success' - a clinical study on the renal oxygen supply/demand relationship in acute kidney injury. Crit Care Med 2010;38:1695-1701.
13.
Park JS, Pasupulati R, Feldkamp T, Roeser NF, Weinberg JM: Cyclophilin D and the mitochondrial permeability transition in kidney proximal tubules after hypoxic and ischemic injury. Am J Physiol Renal Physiol 2011;301:F134-F150.
14.
Zhan M, Brooks C, Liu F, Sun L, Dong Z: Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 2013;83:568-581.
15.
Brooks C, Wei Q, Cho SG, Dong Z: Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009;119:1275-1285.
16.
Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, Feuerstein D, Kaskel FJ, Tellis V, Devarajan P: Activation of mitochondrial apoptotic pathways in human renal allografts after ischemia-reperfusion injury. Transplantation 2003;76:50-54.
17.
Funk JA, Schnellmann RG: Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury. Toxicol Appl Pharmacol 2013;273:345-354.
18.
Hall AM, Rhodes GJ, Sandoval RM, Corridon PR, Molitoris BA: In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury. Kidney Int 2013;83:72-83.
19.
Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004;351:159-169.
20.
Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S: Renal blood flow in sepsis. Crit Care 2005;9:R363-R374.
21.
Brenner M, Schaer GL, Mallory DL, Suffredini AF, Parrillo JE: Detection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheter. Chest 1990;98:170-179.
22.
Heemskerk AEJ, et al: Renal function and oxygen consumption during bacteremia and endotoxaemia in rats. Nephrol Dial Transplant 1997;12:1586-1594.
23.
Vaz AJ: Low fractional excretion of urine sodium in acute renal failure due to sepsis. Arch Intern Med 1983;143:738-739.
24.
Langenberg C, Bagshaw SM, May CN, Bellomo R: The histopathology of septic acute kidney injury: a systematic review. Crit Care 2008;12:R38.
25.
Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-Sharif MR, Khankin EV, Saintgeniez M, David S, Burstein D, Karumanchi SA, Stillman IE, Arany Z, Parikh SM: PGC-1alpha promotes recovery after acute kidney injury during systemic inflammation in mice. J Clin Invest 2011;121:4003-4014.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.